These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26305474)

  • 1. Vascular Proteomics Reveal Novel Proteins Involved in SMC Phenotypic Change: OLR1 as a SMC Receptor Regulating Proliferation and Inflammatory Response.
    Kang DH; Choi M; Chang S; Lee MY; Lee DJ; Choi K; Park J; Han EC; Hwang D; Kwon K; Jo H; Choi C; Kang SW
    PLoS One; 2015; 10(8):e0133845. PubMed ID: 26305474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
    Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
    Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype.
    Cao T; Zhang L; Yao LL; Zheng F; Wang L; Yang JY; Guo LY; Li XY; Yan YW; Pan YM; Jiang M; Chen L; Tang JM; Chen SY; Wang JN
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2772-2782. PubMed ID: 28693920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury.
    Zhang Y; Zhang Y; Li W; Wang P; Gu R; Feng Y; Wei S; Peng K; Zhang Y; Su L; Wang Q; Li D; Yang D; Wong WT; Yang Y; Ma S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
    Dong LH; Wen JK; Miao SB; Jia Z; Hu HJ; Sun RH; Wu Y; Han M
    Cell Res; 2010 Nov; 20(11):1252-62. PubMed ID: 20661261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKLF1 aggravates neointimal hyperplasia by inhibiting apoptosis of vascular smooth muscle cells through PI3K/AKT/NF-κB signaling.
    Duan Y; Zhang Y; Qu C; Yu W; Tana ; Shen C
    Biomed Pharmacother; 2019 Sep; 117():108986. PubMed ID: 31387172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.
    Yang J; Li S; Wang Q; Yang D
    Mol Med Rep; 2019 Aug; 20(2):1436-1442. PubMed ID: 31173198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
    Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
    Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.
    Wang L; Zheng J; Bai X; Liu B; Liu CJ; Xu Q; Zhu Y; Wang N; Kong W; Wang X
    Circ Res; 2009 Mar; 104(5):688-98. PubMed ID: 19168437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
    Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
    Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury.
    Pellet-Many C; Mehta V; Fields L; Mahmoud M; Lowe V; Evans I; Ruivo J; Zachary I
    Cardiovasc Res; 2015 Nov; 108(2):288-98. PubMed ID: 26410366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
    Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
    Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
    Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
    Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular injury activates the ELK1/SND1/SRF pathway to promote vascular smooth muscle cell proliferative phenotype and neointimal hyperplasia.
    Su C; Liu M; Yao X; Hao W; Ma J; Ren Y; Gao X; Xin L; Ge L; Yu Y; Wei M; Yang J
    Cell Mol Life Sci; 2024 Jan; 81(1):59. PubMed ID: 38279051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lysine-specific demethylase 1A suppresses neointimal hyperplasia by targeting bone morphogenetic protein 2 and mediating vascular smooth muscle cell phenotype.
    Zhang X; Huang T; Zhai H; Peng W; Zhou Y; Li Q; Yang H
    Cell Prolif; 2020 Jan; 53(1):e12711. PubMed ID: 31737960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.